153 related articles for article (PubMed ID: 36843435)
21. Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub-Saharan Africa: Systematic review and meta-analysis.
Surial B; Wyser D; Béguelin C; Ramírez-Mena A; Rauch A; Wandeler G
Liver Int; 2021 Apr; 41(4):710-719. PubMed ID: 33220137
[TBL] [Abstract][Full Text] [Related]
22. Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus.
Mo P; Zhu Q; Teter C; Yang R; Deng L; Yan Y; Chen J; Zeng J; Gui XE
Int J Infect Dis; 2014 Nov; 28():95-100. PubMed ID: 25218771
[TBL] [Abstract][Full Text] [Related]
23. Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California.
Gish RG; Yi DH; Kane S; Clark M; Mangahas M; Baqai S; Winters MA; Proudfoot J; Glenn JS
J Gastroenterol Hepatol; 2013 Sep; 28(9):1521-5. PubMed ID: 23574043
[TBL] [Abstract][Full Text] [Related]
24. Latent Tuberculosis Infection Test Agreement in the National Health and Nutrition Examination Survey.
Ghassemieh BJ; Attia EF; Koelle DM; Mancuso JD; Narita M; Horne DJ
Am J Respir Crit Care Med; 2016 Aug; 194(4):493-500. PubMed ID: 26890477
[TBL] [Abstract][Full Text] [Related]
25. Latent Tuberculosis Infection Testing Practices in a Large US Integrated Healthcare System.
Ku JH; Fischer H; Qian LX; Li K; Skarbinski J; Shaw S; Bruxvoort KJ; Lewin BJ; Spence BC; Tartof SY
Clin Infect Dis; 2024 May; 78(5):1304-1312. PubMed ID: 38207124
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007.
Spradling PR; Richardson JT; Buchacz K; Moorman AC; Brooks JT;
J Viral Hepat; 2010 Dec; 17(12):879-86. PubMed ID: 20158604
[TBL] [Abstract][Full Text] [Related]
28. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.
Mirzazadeh A; Kahn JG; Haddad MB; Hill AN; Marks SM; Readhead A; Barry PM; Flood J; Mermin JH; Shete PB
PLoS One; 2021; 16(4):e0249012. PubMed ID: 33793612
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052.
Greer AE; Ou SS; Wilson E; Piwowar-Manning E; Forman MS; McCauley M; Gamble T; Ruangyuttikarn C; Hosseinipour MC; Kumarasamy N; Nyirenda M; Grinsztejn B; Pilotto JH; Kosashunhanan N; Gonçalves de Melo M; Makhema J; Akelo V; Panchia R; Badal-Faesen S; Chen YQ; Cohen MS; Eshleman SH; Thio CL; Valsamakis A
J Acquir Immune Defic Syndr; 2017 Dec; 76(4):388-393. PubMed ID: 28749822
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of latent tuberculosis infection and associated risk factors in an urban African setting.
Kizza FN; List J; Nkwata AK; Okwera A; Ezeamama AE; Whalen CC; Sekandi JN
BMC Infect Dis; 2015 Mar; 15():165. PubMed ID: 25879423
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
Baseke J; Musenero M; Mayanja-Kizza H
Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
[TBL] [Abstract][Full Text] [Related]
32. High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa.
Msomi N; Naidoo K; Yende-Zuma N; Padayatchi N; Govender K; Singh JA; Abdool-Karim S; Abdool-Karim Q; Mlisana K
BMC Infect Dis; 2020 Nov; 20(1):847. PubMed ID: 33198649
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
Bersoff-Matcha SJ; Cao K; Jason M; Ajao A; Jones SC; Meyer T; Brinker A
Ann Intern Med; 2017 Jun; 166(11):792-798. PubMed ID: 28437794
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study.
Hønge BL; Jespersen S; Medina C; Té Dda S; da Silva ZJ; Lewin S; Østergaard L; Erikstrup C; Wejse C; Laursen AL; Krarup H;
PLoS One; 2014; 9(6):e99971. PubMed ID: 24915064
[TBL] [Abstract][Full Text] [Related]
35. Estimated Latent Tuberculosis Infection Prevalence and Tuberculosis Reactivation Rates Among Non-U.S.-Born Residents in the United States, from the 2011-2012 National Health and Nutrition Examination Survey.
Yelk Woodruff R; Hill A; Marks S; Navin T; Miramontes R
J Immigr Minor Health; 2021 Aug; 23(4):806-812. PubMed ID: 32761297
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana.
Matthews PC; Beloukas A; Malik A; Carlson JM; Jooste P; Ogwu A; Shapiro R; Riddell L; Chen F; Luzzi G; Jaggernath M; Jesuthasan G; Jeffery K; Ndung'u T; Goulder PJ; Geretti AM; Klenerman P
PLoS One; 2015; 10(7):e0134037. PubMed ID: 26218239
[TBL] [Abstract][Full Text] [Related]
37. Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS).
Bixler D; Zhong Y; Ly KN; Moorman AC; Spradling PR; Teshale EH; Rupp LB; Gordon SC; Boscarino JA; Schmidt MA; Daida YG; Holmberg SD;
Clin Infect Dis; 2019 Mar; 68(6):956-963. PubMed ID: 30060032
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of latent tuberculosis and bloodborne virus infection in a homeless population.
Aldridge RW; Hayward AC; Hemming S; Yates SK; Ferenando G; Possas L; Garber E; Watson JM; Geretti AM; McHugh TD; Lipman M; Story A
Thorax; 2018 Jun; 73(6):557-564. PubMed ID: 29378859
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
Kruse RL; Kramer JR; Tyson GL; Duan Z; Chen L; El-Serag HB; Kanwal F
Hepatology; 2014 Dec; 60(6):1871-8. PubMed ID: 25065513
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis.
Lomtadze N; Kupreishvili L; Salakaia A; Vashakidze S; Sharvadze L; Kempker RR; Magee MJ; del Rio C; Blumberg HM
PLoS One; 2013; 8(12):e83892. PubMed ID: 24367617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
